Diclofenac (Voltaren) and risk of cardiovascular events (heart attack and stroke)
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Diclofenac Oral Solution: Package Insert - Drugs.com
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology
Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM
Relative risk of upper-GI complications with different NSAIDs. Note:... | Download Scientific Diagram
Diclofenac use poses an increased cardiovascular health risk compared to the use of other NSAIDs. : r/science
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison - The Lancet
Relationship Between Diclofenac Dose and Risk of Gastrointestinal and Cardiovascular Events: Meta-Regression Based on Two Systematic Literature Reviews - ScienceDirect
Diclofenac use and cardiovascular risks: series of nationwide cohort studies | The BMJ
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation - ScienceDirect
Cardiovascular effects and safety of (non-aspirin) NSAIDs | Nature Reviews Cardiology
Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
Diclofenac patch: Dosage, Uses, Side Effects & Reviews
IJERPH | Free Full-Text | Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System
Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials - Stiller - 2022 - Journal of Internal Medicine - Wiley Online Library
Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis | NEJM
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, USP These highlights do not include all the information needed to use DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for
Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users | Scientific Reports
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for C
NSAIDs and Gastrointestinal Complications - Sports Medicine Review
Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction | Journal of the American College of Cardiology
NSAIDs and cardiovascular risk | Semantic Scholar
Pharmaceutics | Free Full-Text | Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review
